Drug Profile
NIP 261
Alternative Names: NIP 200Latest Information Update: 31 Jan 2008
Price :
$50
*
At a glance
- Originator Nissan Chemical Industries
- Class Anti-ischaemics; Antihyperlipidaemics; Small molecules
- Mechanism of Action Lipoprotein lipase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 04 Jun 1998 Suspended-Preclinical for Hyperlipidaemia in Japan (Unknown route)